Functional characterization of CDK5 and CDK5R1 mutations identified in patients with non-syndromic intellectual disability

Silvia Moncini, Paola Castronovo, Alessandra Murgia, Silvia Russo, Maria Francesca Bedeschi, Marta Lunghi, Angelo Selicorni, Maria Teresa Bonati, Paola Riva, Marco Venturin

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Cyclin-dependent kinase 5 (CDK5) and cyclin-dependent kinase 5, regulatory subunit 1 (CDK5R1), encoding CDK5 activator p35, have a fundamental role in central nervous system (CNS) development and function, and are involved in the pathogenesis of several neurodegenerative disorders, thus constituting strong candidate genes for the onset of intellectual disability (ID). We carried out a mutation screening of CDK5 and CDK5R1 coding regions and CDK5R1 3′-UTR on a cohort of 360 patients with non-syndromic ID (NS-ID) using denaturing high performance liquid chromatography (DHPLC) and direct sequencing. We found one novel silent mutation in CDK5 and one novel silent mutation in CDK5R1 coding regions, three novel intronic variations in CDK5, not causing any splicing defect, and four novel heterozygous variations in CDK5R1 3′-UTR. None of these variations was present in 450 healthy controls and single-nucleotide polymorphism (SNP) databases. The functional study of CDK5R1 p.A108V mutation evidenced an impaired p35 cleavage by the calcium-dependent protease calpain. Moreover, luciferase constructs containing the CDK5R1 3′-UTR mutations showed altered gene expression levels. Eight known polymorphisms were also identified displaying different frequencies in NS-ID patients compared with the controls. In particular, the minor allele of CDK5R1 3′-UTR rs735555 polymorphism was associated with increased risk for NS-ID. In conclusion, our data suggest that mutations and polymorphisms in CDK5 and CDK5R1 genes may contribute to the onset of the NS-ID phenotype.

Original languageEnglish
Pages (from-to)283-293
Number of pages11
JournalJournal of Human Genetics
Volume61
Issue number4
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Cyclin-Dependent Kinase 5
Intellectual Disability
Mutation
3' Untranslated Regions
Calpain

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Functional characterization of CDK5 and CDK5R1 mutations identified in patients with non-syndromic intellectual disability. / Moncini, Silvia; Castronovo, Paola; Murgia, Alessandra; Russo, Silvia; Bedeschi, Maria Francesca; Lunghi, Marta; Selicorni, Angelo; Bonati, Maria Teresa; Riva, Paola; Venturin, Marco.

In: Journal of Human Genetics, Vol. 61, No. 4, 01.04.2016, p. 283-293.

Research output: Contribution to journalArticle

Moncini, Silvia ; Castronovo, Paola ; Murgia, Alessandra ; Russo, Silvia ; Bedeschi, Maria Francesca ; Lunghi, Marta ; Selicorni, Angelo ; Bonati, Maria Teresa ; Riva, Paola ; Venturin, Marco. / Functional characterization of CDK5 and CDK5R1 mutations identified in patients with non-syndromic intellectual disability. In: Journal of Human Genetics. 2016 ; Vol. 61, No. 4. pp. 283-293.
@article{4b7238112eb4435fb42a74fb09a10f97,
title = "Functional characterization of CDK5 and CDK5R1 mutations identified in patients with non-syndromic intellectual disability",
abstract = "Cyclin-dependent kinase 5 (CDK5) and cyclin-dependent kinase 5, regulatory subunit 1 (CDK5R1), encoding CDK5 activator p35, have a fundamental role in central nervous system (CNS) development and function, and are involved in the pathogenesis of several neurodegenerative disorders, thus constituting strong candidate genes for the onset of intellectual disability (ID). We carried out a mutation screening of CDK5 and CDK5R1 coding regions and CDK5R1 3′-UTR on a cohort of 360 patients with non-syndromic ID (NS-ID) using denaturing high performance liquid chromatography (DHPLC) and direct sequencing. We found one novel silent mutation in CDK5 and one novel silent mutation in CDK5R1 coding regions, three novel intronic variations in CDK5, not causing any splicing defect, and four novel heterozygous variations in CDK5R1 3′-UTR. None of these variations was present in 450 healthy controls and single-nucleotide polymorphism (SNP) databases. The functional study of CDK5R1 p.A108V mutation evidenced an impaired p35 cleavage by the calcium-dependent protease calpain. Moreover, luciferase constructs containing the CDK5R1 3′-UTR mutations showed altered gene expression levels. Eight known polymorphisms were also identified displaying different frequencies in NS-ID patients compared with the controls. In particular, the minor allele of CDK5R1 3′-UTR rs735555 polymorphism was associated with increased risk for NS-ID. In conclusion, our data suggest that mutations and polymorphisms in CDK5 and CDK5R1 genes may contribute to the onset of the NS-ID phenotype.",
author = "Silvia Moncini and Paola Castronovo and Alessandra Murgia and Silvia Russo and Bedeschi, {Maria Francesca} and Marta Lunghi and Angelo Selicorni and Bonati, {Maria Teresa} and Paola Riva and Marco Venturin",
year = "2016",
month = "4",
day = "1",
doi = "10.1038/jhg.2015.144",
language = "English",
volume = "61",
pages = "283--293",
journal = "Journal of Human Genetics",
issn = "1434-5161",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Functional characterization of CDK5 and CDK5R1 mutations identified in patients with non-syndromic intellectual disability

AU - Moncini, Silvia

AU - Castronovo, Paola

AU - Murgia, Alessandra

AU - Russo, Silvia

AU - Bedeschi, Maria Francesca

AU - Lunghi, Marta

AU - Selicorni, Angelo

AU - Bonati, Maria Teresa

AU - Riva, Paola

AU - Venturin, Marco

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Cyclin-dependent kinase 5 (CDK5) and cyclin-dependent kinase 5, regulatory subunit 1 (CDK5R1), encoding CDK5 activator p35, have a fundamental role in central nervous system (CNS) development and function, and are involved in the pathogenesis of several neurodegenerative disorders, thus constituting strong candidate genes for the onset of intellectual disability (ID). We carried out a mutation screening of CDK5 and CDK5R1 coding regions and CDK5R1 3′-UTR on a cohort of 360 patients with non-syndromic ID (NS-ID) using denaturing high performance liquid chromatography (DHPLC) and direct sequencing. We found one novel silent mutation in CDK5 and one novel silent mutation in CDK5R1 coding regions, three novel intronic variations in CDK5, not causing any splicing defect, and four novel heterozygous variations in CDK5R1 3′-UTR. None of these variations was present in 450 healthy controls and single-nucleotide polymorphism (SNP) databases. The functional study of CDK5R1 p.A108V mutation evidenced an impaired p35 cleavage by the calcium-dependent protease calpain. Moreover, luciferase constructs containing the CDK5R1 3′-UTR mutations showed altered gene expression levels. Eight known polymorphisms were also identified displaying different frequencies in NS-ID patients compared with the controls. In particular, the minor allele of CDK5R1 3′-UTR rs735555 polymorphism was associated with increased risk for NS-ID. In conclusion, our data suggest that mutations and polymorphisms in CDK5 and CDK5R1 genes may contribute to the onset of the NS-ID phenotype.

AB - Cyclin-dependent kinase 5 (CDK5) and cyclin-dependent kinase 5, regulatory subunit 1 (CDK5R1), encoding CDK5 activator p35, have a fundamental role in central nervous system (CNS) development and function, and are involved in the pathogenesis of several neurodegenerative disorders, thus constituting strong candidate genes for the onset of intellectual disability (ID). We carried out a mutation screening of CDK5 and CDK5R1 coding regions and CDK5R1 3′-UTR on a cohort of 360 patients with non-syndromic ID (NS-ID) using denaturing high performance liquid chromatography (DHPLC) and direct sequencing. We found one novel silent mutation in CDK5 and one novel silent mutation in CDK5R1 coding regions, three novel intronic variations in CDK5, not causing any splicing defect, and four novel heterozygous variations in CDK5R1 3′-UTR. None of these variations was present in 450 healthy controls and single-nucleotide polymorphism (SNP) databases. The functional study of CDK5R1 p.A108V mutation evidenced an impaired p35 cleavage by the calcium-dependent protease calpain. Moreover, luciferase constructs containing the CDK5R1 3′-UTR mutations showed altered gene expression levels. Eight known polymorphisms were also identified displaying different frequencies in NS-ID patients compared with the controls. In particular, the minor allele of CDK5R1 3′-UTR rs735555 polymorphism was associated with increased risk for NS-ID. In conclusion, our data suggest that mutations and polymorphisms in CDK5 and CDK5R1 genes may contribute to the onset of the NS-ID phenotype.

UR - http://www.scopus.com/inward/record.url?scp=84964922273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964922273&partnerID=8YFLogxK

U2 - 10.1038/jhg.2015.144

DO - 10.1038/jhg.2015.144

M3 - Article

AN - SCOPUS:84964922273

VL - 61

SP - 283

EP - 293

JO - Journal of Human Genetics

JF - Journal of Human Genetics

SN - 1434-5161

IS - 4

ER -